Cargando…

Clinical management of patients with Cushing syndrome treated with mifepristone: consensus recommendations

BACKGROUND: While surgery is the first-line treatment for patients with endogenous hypercortisolism (Cushing syndrome [CS]), mifepristone has been shown to be a beneficial medical treatment option, as demonstrated in the SEISMIC (Study of the Efficacy and Safety of Mifepristone in the Treatment of E...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brown, David R., East, Honey E., Eilerman, Bradley S., Gordon, Murray B., King, Elizabeth E., Knecht, Laura A., Salke, Brandon, Samson, Susan L., Yuen, Kevin C. J., Yau, Hanford
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7596972/ https://www.ncbi.nlm.nih.gov/pubmed/33292727 http://dx.doi.org/10.1186/s40842-020-00105-4

Ejemplares similares

ODP322 Impact of Mifepristone on Liver Function and Resolution of Liver Steatosis in Patients with Cushing Syndrome – A Case Study
por: East, Honey E, et al.
Publicado: (2022)

Mifepristone as Bridge or Adjunct Therapy in the Management of Challenging Cushing Disease Cases
por: Chang, Alice Y, et al.
Publicado: (2021)

THU621 Mifepristone In Exogenous Cushing's Syndrome
por: Priyadarshan, Swetha, et al.
Publicado: (2023)

Mifepristone for Treatment of Metabolic Syndrome: Beyond Cushing’s Syndrome
por: Díaz-Castro, Francisco, et al.
Publicado: (2020)

Hypokalemia associated with mifepristone use in the treatment of Cushing’s syndrome
por: Sai, Katta, et al.
Publicado: (2019)

Global clinical response in Cushing’s syndrome patients treated with mifepristone
por: Katznelson, Laurence, et al.
Publicado: (2014)

Mifepristone Treatment in Four Cases of Primary Bilateral Macronodular Adrenal Hyperplasia (BMAH)
por: Cohan, Pejman, et al.
Publicado: (2019)

Mifepristone Improves Octreotide Efficacy in Resistant Ectopic Cushing's Syndrome
por: Moraitis, Andreas G., et al.
Publicado: (2016)

Improvement in Insulin Sensitivity During Mifepristone Treatment of Cushing Syndrome:Early and Late Effects
por: Wallia, Amisha, et al.
Publicado: (2013)

The Development of Hypogonadotropic Hypogonadism After Starting Low Dose Mifepristone for Cushing’s Syndrome
por: Rowell, Jennifer Voigt
Publicado: (2021)

Exogenous Cushing Syndrome and Hip Fracture Due to Over-the-Counter Supplement (Artri King)
por: Saad-Omer, Suhail M, et al.
Publicado: (2023)

SUN-186 Case Report: Mifepristone Taper in an Individual with Equivocal Cushing’s Syndrome Screening Tests
por: Martin, Christopher, et al.
Publicado: (2020)

Mifepristone induced liver injury in a patient with Cushing syndrome: a case report and review of the literature
por: Ault, Taylor A., et al.
Publicado: (2023)

MON-413 First Reported Case of Combined High-Dose Mifepristone Therapy and Oral Contraceptive in Inducing Reversible Cholestatic Hepatitis in a Patient with Cushing Disease
por: Youssef, Nancy, et al.
Publicado: (2019)

Acute generalized exanthematous pustulosis induced by mifepristone
por: Kirsch, Brandon M., et al.
Publicado: (2015)

Mifepristone, preemption, and public health federalism
por: Zettler, Patricia J, et al.
Publicado: (2022)

Mifepristone-Induced Hypothyroidism
por: Kalara, Niketa, et al.
Publicado: (2023)

Computational repositioning and preclinical validation of mifepristone for human vestibular schwannoma
por: Sagers, Jessica E., et al.
Publicado: (2018)

Sustained weight loss in patients treated with mifepristone for Cushing’s syndrome: a follow-up analysis of the SEISMIC study and long-term extension
por: Fein, Henry G., et al.
Publicado: (2015)

Evaluation of Evidence of Adrenal Insufficiency in Trials of Normocortisolemic Patients Treated With Mifepristone
por: Yuen, Kevin C. J., et al.
Publicado: (2017)

SUN-460 Anticipating Hypokalemia in Patients With ACTH-Dependent Cushing Syndrome Treated With Mifepristone: Utilization of Cortisol and ACTH Levels to Identify At-Risk Patients
por: Moraitis, Andreas, et al.
Publicado: (2019)

Publisher Correction: Computational repositioning and preclinical validation of mifepristone for human vestibular schwannoma
por: Sagers, Jessica E., et al.
Publicado: (2018)

Resetting the Stress System with a Mifepristone Challenge
por: Dalm, Sergiu, et al.
Publicado: (2018)

Cost of goods sold analysis and recommendations to reduce costs of co-packaged mifepristone–misoprostol for medical abortion
por: Chinery, Lester, et al.
Publicado: (2020)

Mifepristone modulates serotonin transporter function
por: Li, Chaokun, et al.
Publicado: (2014)

Medication Abortion With Pharmacist Dispensing of Mifepristone
por: Grossman, Daniel, et al.
Publicado: (2021)

Mifepristone Increases Thyroid Hormone Requirements in Patients With Central Hypothyroidism: A Multicenter Study
por: Guarda, Francisco J, et al.
Publicado: (2019)

Mifepristone Repurposing in Treatment of High-Grade Gliomas
por: Llaguno-Munive, Monserrat, et al.
Publicado: (2021)

Mifepristone and Misoprostol for Undesired Pregnancy of Unknown Location
por: Goldberg, Alisa B., et al.
Publicado: (2022)

Clinical Utility of Mifepristone: Apprising the Expanding Horizons
por: Karena, Zalak V, et al.
Publicado: (2022)

SUN-396 Subclinical Cushing's Syndrome: Should We Treat?
por: Proudan, Nikoletta, et al.
Publicado: (2019)

X-Ray Crystal Structure of the Ancestral 3-Ketosteroid Receptor–Progesterone–Mifepristone Complex Shows Mifepristone Bound at the Coactivator Binding Interface
por: Colucci, Jennifer K., et al.
Publicado: (2013)

A Pilot Study of Mifepristone in Combat-Related PTSD
por: Golier, Julia A., et al.
Publicado: (2012)

Successful conservative management with methotrexate and mifepristone of cervical pregnancy
por: Shrestha, Eliza, et al.
Publicado: (2011)

Mifepristone improves chemo-radiation response in glioblastoma xenografts
por: Llaguno-Munive, Monserrat, et al.
Publicado: (2013)

Therapeutic effects of mifepristone combined with Gestrinone on patients with endometriosis
por: Xue, Hui-Ling, et al.
Publicado: (2016)

Mifepristone: An Uncommon Cause of Drug-Induced Liver Injury
por: Shah, Ishani, et al.
Publicado: (2019)

The new application of mifepristone in the relief of adenomyosis-caused dysmenorrhea
por: Che, Xuan, et al.
Publicado: (2020)

Interstitial Ectopic Pregnancy: The Role of Mifepristone in the Medical Treatment
por: Stabile, Guglielmo, et al.
Publicado: (2021)

Anticancer effects of mifepristone on human uveal melanoma cells
por: Alvarez, Prisca Bustamante, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2jd431is7g222t9u97j5je9qku